CC
ACAD icon

Clearline Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

Clearline Capital’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-22,812
Closed -$636K – 50
2017
Q2 		$636K Buy
22,812
+6,430
+39% +$179K 0.4% 33
2017
Q1 		$563K Buy
+16,382
New +$563K 0.27% 49